As Connecticut residents may know, it is important for drug manufacturers to properly label medications. The containers should contain the name of the medication, the dosage, instructions concerning the use of the drug as well as adequate warning of problems associated with the drug. While some dosing errors are made by prescribers or pharmacists, others may be the result of manufacturer error.
A case in France involved an alleged connection to Teva Pharmaceuticals. In June 2013, six individuals died after taking medication labeled as furosemide, a heart drug. The vials containing the medication were mislabeled. Instead of furosemide, the vials contained zopiclone, a sedative. Following an investigation of the manufacturing plant, the French authorities were unable to find negligence or mishandling. Later, it was reported that counterfeit drugs were found in a warehouse. Other packages were shipped to France from India and passed through a major French airport. The drugs were seized by authorities.
In another case, a New Zealand woman suffered burns due to a procedure where an acetic acid mixture was used in a concentrated format. The mixture required dilution to be safely used. The manufacturer labeled the mixture incorrectly, leading to the injury.
Manufacturers are obligated to label ingredients correctly. The drugs or solutions must conform to safe manufacturing practices. In the event that this is not done, a patient may be severely injured or killed. The manufacturer might be held liable for financial damages due to negligence. In the event that mislabeling happened due to pharmacy error, the pharmacy and its employee may be considered negligent. A person who has been harmed as a result of medication error may want to meet with a medical malpractice attorney in order to determine how to proceed with seeking financial compensation for the damages that have been incurred.